IRIS
DALLABONA, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.575
AS - Asia 4.050
EU - Europa 2.800
SA - Sud America 542
AF - Africa 184
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
Totale 12.166
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.483
SG - Singapore 1.471
CN - Cina 1.090
IT - Italia 853
VN - Vietnam 659
SE - Svezia 440
IE - Irlanda 423
BR - Brasile 413
HK - Hong Kong 344
FI - Finlandia 225
FR - Francia 194
DE - Germania 168
ZA - Sudafrica 126
NL - Olanda 118
GB - Regno Unito 111
BD - Bangladesh 79
IN - India 73
RU - Federazione Russa 71
TR - Turchia 64
UA - Ucraina 57
AR - Argentina 52
CA - Canada 48
BE - Belgio 30
IQ - Iraq 28
JP - Giappone 28
KR - Corea 28
MX - Messico 28
AT - Austria 26
PK - Pakistan 24
PL - Polonia 24
ID - Indonesia 22
EC - Ecuador 19
ES - Italia 19
PH - Filippine 18
UZ - Uzbekistan 16
VE - Venezuela 14
CO - Colombia 13
MA - Marocco 12
SA - Arabia Saudita 12
CI - Costa d'Avorio 10
LT - Lituania 10
PE - Perù 10
TW - Taiwan 10
IL - Israele 9
IR - Iran 9
UY - Uruguay 9
AZ - Azerbaigian 8
EG - Egitto 8
KE - Kenya 8
TH - Thailandia 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
AU - Australia 6
CZ - Repubblica Ceca 6
DZ - Algeria 6
EU - Europa 6
JO - Giordania 5
LB - Libano 5
TN - Tunisia 5
MY - Malesia 4
PT - Portogallo 4
PY - Paraguay 4
AL - Albania 3
BH - Bahrain 3
DK - Danimarca 3
GE - Georgia 3
LK - Sri Lanka 3
NI - Nicaragua 3
OM - Oman 3
QA - Qatar 3
RO - Romania 3
CH - Svizzera 2
CR - Costa Rica 2
CY - Cipro 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LY - Libia 2
MD - Moldavia 2
NP - Nepal 2
PA - Panama 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
Totale 12.155
Salva come PNG Salva come JPEG
Città #
Singapore 754
Ashburn 540
San Jose 430
Dallas 410
Dublin 410
Santa Clara 386
Chandler 367
Hong Kong 323
Beijing 283
Parma 216
Ho Chi Minh City 204
Ann Arbor 170
Boardman 160
Dearborn 140
Los Angeles 140
Hanoi 132
Johannesburg 111
New York 96
Shanghai 88
Lauterbourg 87
Jacksonville 78
Nanjing 77
Hefei 75
Princeton 68
Izmir 53
Bologna 50
Moscow 44
Milan 43
Wilmington 43
Munich 41
Columbus 39
Helsinki 36
São Paulo 34
Jinan 31
Buffalo 30
Da Nang 30
Des Moines 30
Brussels 29
Nanchang 28
Shenyang 28
Nuremberg 25
San Mateo 25
Woodbridge 25
Marseille 24
Haiphong 23
Tokyo 23
Atlanta 21
Kunming 21
Biên Hòa 20
Changsha 19
Seoul 19
Guangzhou 18
Houston 18
London 18
The Dalles 18
Warsaw 18
Hebei 17
Toronto 17
Turku 17
Belo Horizonte 16
Council Bluffs 16
Vienna 16
Chicago 15
Hangzhou 15
Seattle 15
Tashkent 15
Tianjin 15
Brooklyn 14
Colchester 14
Falls Church 14
Reggio Emilia 14
Zhengzhou 14
Frankfurt am Main 13
Redmond 13
Rome 13
Catania 12
Hải Dương 12
Jakarta 12
Orem 12
Phoenix 12
Piacenza 12
Rio de Janeiro 12
Denver 11
Fontanellato 11
Mexico City 11
Montreal 11
Abidjan 10
Baghdad 10
Bengaluru 10
Chennai 10
Stockholm 10
Bremen 9
Can Tho 9
Ninh Bình 9
Pistoia 9
Baku 8
Bari 8
Lấp Vò 8
Manchester 8
Nairobi 8
Totale 7.206
Salva come PNG Salva come JPEG
Nome #
A yeast-based repurposing approach revealed modulation of dNTP pool as a therapeutic target to treat mitochondrial DNA depletion syndromes 213
In Vivo Treatment with a Standardized Green Tea Extract Restores Cardiomyocyte Contractility in Diabetic Rats by Improving Mitochondrial Function through SIRT1 Activation 212
Decline of cardiomyocyte contractile performance and bioenergetic function in socially stressed male rats 195
DNA polymerase [gamma] and disease: what we have learned from yeast 195
Repeated witness social stress causes cardiomyocyte contractile impairment and intracellular Ca2+ derangement in female rats 194
Sabotage at the powerhouse? Unraveling the Molecular Target of 2-Isopropylbenzaldehyde Thiosemicarbazone, a Specific Inhibitor of Aflatoxin Biosynthesis and Sclerotia Development in Aspergillus flavus, Using Yeast as a Model System 184
A single nucleotide polymorphism in the DNA polymerase gamma gene of Saccharomyces cerevisiae laboratory strains is responsible for increased mitochondrial DNA mutability 174
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 171
Pathogenic variants in glutamyl-tRNAGlnamidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder 168
Defective PITRM1 mitochondrial peptidase is associated with Aβ amyloidotic neurodegeneration 166
A homozygous mutation in LYRM7/MZM1L associated with early onset encephalopathy, lactic acidosis and severe reduction of mitochondrial complex III activity. 165
A yeast-based repurposing approach for the treatment of mitochondrial DNA depletion syndromes led to the identification of molecules able to modulate the dNTP pool 164
Yeast as a model system to shed light on the role of the human disease protein Mpv17 162
Elongator-dependent modification of cytoplasmic tRNALysUUU is required for mitochondrial function under stress conditions 162
Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy 162
Drug Drop Test: How to Quickly Identify Potential Therapeutic Compounds for Mitochondrial Diseases Using Yeast Saccharomyces cerevisiae 161
Yeast as a model of mitochondrial dysfunctions: neurodegenerative diseases and cancer. 161
Pathological alleles of MPV17 modeled in the yeast Saccharomyces cerevisiae orthologous gene SYM1 reveal their inability to take part in a high molecular weight complex 160
Yeast as a model system for diseases associated with defective coenzyme a metabolism 158
The identification of beneficial molecules for mitochondrial diseases: Saccharomyces cerevisiae as powerful model 157
The Power of Yeast in Modelling Human Nuclear Mutations Associated with Mitochondrial Diseases 156
A Novel Homozygous YARS2 Mutation in Two Italian Siblings and a Review of Literature 153
A yeast-based screening unravels potential therapeutic molecules for mitochondrial diseases associated with dominant ant1 mutations 151
Yeast models of human MTO1 variants confirm two diagnoses of mitochondrial modopathy 149
Dominance of yeast aac2R96H and aac2R252G mutations, equivalent to pathological mutations in ant1, is due to gain of function 148
Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive externalophthalmoplegia in humans 147
Saccharomyces cerevisiae as a model for the identification of beneficial molecules for mitochondrial diseases. 143
Saccharomyces cerevisiae as a tool for studying mutations in nuclear genes involved in diseases caused by mitochondrial DNA instability 142
Mitochondrial Aminoacyl-tRNA Synthetase: The Power Of Yeast In Modeling Human Pathological Mutations 141
Genetic, physiological and molecular characterization of MPV17/SYM1 mutations in S. cerevisiae 141
Sideroblastic anemia with myopathy secondary to novel, pathogenic missense variants in the YARS2 gene 140
Study of the effects of potentially beneficial molecules on the mitochondrial dNTP pool in a model of Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 140
YEAST MODEL FOR NOVEL AARS2 MUTATIONS ASSOCIATED WITH PROGRESSIVE LEUKOENCEPHALOPATHY AND CEREBELLAR ATAXIA 139
Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiae 138
Pathogenic variants in GCSH encoding the moonlighting H-protein cause combined Nonketotic Hyperglycinemia and Lipoate Deficiency 137
DEFECTIVE MITOCHONDRIAL rRNA METHYLTRANSFERASE (MRM2) CAUSES A MELAS-LIKE SYNDROME 137
The power of yeast in modeling human mutations leading to mitochondrial disease:the case of ANT1, YARS2, DNM1L and LYRM7. 137
Characterization of the Saccharomyces cerevisiae SYM1 gene, ortholog of the human desease gene MPV17 137
Modeling human Coenzyme A synthase mutation in yeast reveals altered mitochondrial function, lipid content and iron metabolism 135
Saccharomyces cerevisiae as a system to discover beneficial molecules for mitochondrial diseases 131
Yeast expression of mammalian Onzin and fungal FCR1 suggests ancestral functions of PLAC8 proteins in mitochondrial metabolism and DNA repair 129
Childhood obsessive-compulsive disorder, epigenetics, and heterochrony: An evolutionary and developmental approach 128
Uncovering a Novel Pathogenic Mechanism of BCS1L in Mitochondrial Disorders: Insights from Functional Studies on the c.38A>G Variant. 128
SYM1, the yeast ortholog of the MPV17 human disease gene, is required for TCA function, mtDNA stability and mitochondrial morphology in stress conditions 128
Mitochondrial aminoacyl‐trna synthetase and disease: The yeast contribution for functional analysis of novel variants 128
Research of potentially therapeutic molecules for Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 127
Modopathies Caused by Mutations in Genes Encoding for Mitochondrial RNA Modifying Enzymes: Molecular Mechanisms and Yeast Disease Models 127
Case Series and DARS2 Variant Analysis in Early Severe Forms With Unexpected Presentations 126
SYM1, the yeast ortholog of the MPV17 human disease gene, is required for TCA function, mtDNA stability and mitochondrial morphology in stress conditions 125
Pathological Role of Mutations in Human MPV17: Saccharomyces cerevisiae as a Model System 124
Epigenetic analyses in forensic medicine: future and challenges 124
MUTATIONS IN THE GENES QRSL1, GATB, AND GATC ENCODING THE SUBUNITS OF GLUTAMYL-TRNA(GLN) AMIDOTRANSFERASE CAUSE A MITOCHONDRIAL DISORDER WITH LETHAL INFANTILE CARDIOMYOPATHY 122
TRMT5 Mutations Cause a Defect in Post-transcriptional Modification of Mitochondrial tRNA Associated with Multiple Respiratory-Chain Deficiencies 120
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 120
In-frame deletion in canine PITRM1 is associated with a severe early-onset epilepsy, mitochondrial dysfunction and neurodegeneration 120
Saccharomyces cerevisiae, a model system to study the effect of mtDNA polymerase mutations associated with PEO in humans. 119
VARS2 and TARS2 Mutations in Patients with Mitochondrial Encephalomyopathies 119
The polymorphism Val158Met in the COMT gene: disrupted dopamine system in fibromyalgia patients? 118
Repurposing Drugs for Mitochondrial Disorders: A Yeast-Based Approach for Complex III Assembly Defects 117
The power of yeast in modeling human mutations: mitochondrial aminoacyl tRNA synthetases and mitochondrial tRNA modifiers 117
Characterization of the BCS1L c.38A>G variant identified in a patient with Biörnstad syndrome 116
Sym1, the yeast ortholog of the MPV17 human disease protein, is a stress-induced bioenergetic and morphogenetic mitochondrial modulator 115
The power of yeast in modeling human mutations leading to mitochondrial disease 114
Mitmed: a multicenter consortium for the identification and characterization of nuclear genes responsisble for human mitochondrial disorders 114
Sym1, the yeast ortholog of the MPV17 human disease protein, is a stress-induced bioenergetic and morphogenetic mitochondrial modulator 113
A simple organism to address big questions: how Saccharomyces cerevisiae can support mitochondrial medicine 111
Mutations in the mitochondrial tryptophanyl-tRNA synthetase cause growth retardation and progressive leukoencephalopathy 111
Functional analysis of missense DARS2 variants in siblings with leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation 110
De novo DNM1L pathogenic variant associated with lethal encephalocardiomyopathy and a literature review 109
LYRM7 mutations cause a multifocal cavitating leukoencephalopathy with distinct MRI appearance. 108
De Novo DNM1L Pathogenic Variant Associated with Lethal Encephalocardiomyopathy—Case Report and Literature Review 107
A potential link between inflammatory profiles, clinical pain, pain catastrophizing and long‐term outcomes after total knee arthroplasty surgery 106
Predicting the contribution of novel POLG mutations to human disease through analysis in yeast model 106
Epigenetic alterations in prescription opioid misuse: New strategies for precision pain management 106
Transcriptomics on yeast models to deepen the knowledge of mitochondrial disease-associated pathways 103
The Saccharomyces cerevisiae yeast as a model system to study the human mitochondrial DNA depletion syndromes (MDDS) 101
MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast 100
The yeast Saccharomyces cerevisiae as a model to deepen the knowledge about the mitochondrial metallopeptidase PITRM1 in health and disease 99
MITMED: A MULTICENTER CONSORTIUM FOR THE IDENTIFICATION AND CHARACTERIZATION OF NUCLEAR GENES RESPONSIBLE FOR HUMAN MITOCHONDRIAL DISORDERS 99
Yeast-based screening to discover therapies for Complex III assembly defects. 98
Pain mechanistic networks: the development using supervised multivariate data analysis and implications for chronic pain 98
Mitochondrial diseases and the role of the yeast models. 97
The Saccharomyces cerevisiae mitochondrial DNA polymerase and its contribution to the knowledge about human POLG-related disorders 96
Saccharomyces cerevisiae: a powerful organism to study mitochondrial diseases and support mitochondrial medicine 96
Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis. 95
Phenotypic, molecular, and functional characterization of COQ7-related primary CoQ10 deficiency: Hypomorphic variants and two distinct disease entities 94
Recurrent De Novo Dominant Mutations in SLC25A4 Cause Severe Early-Onset Mitochondrial Disease and Loss of Mitochondrial DNA Copy Number 93
An Unusual Case of SUCLA2-related Mitochondrial DNA Depletion Syndrome Who Presented with Hepatopathy Following Chemotherapy: Molecular Analysis and Functional Study 90
Role of ROS in mtDNA instability in ANT1-associated adPEO 88
Identification of potential therapeutic compounds for mitochondrial disorders due to mutations in mitochondrial respiratory chain assembly factors by exploiting yeast models 84
The first recessive pathological mutation in the adenine nucleotide translocator: yeast as a model system 84
Yeast as a model system to propose therapies for Mitochondrial Complex III Deficiency 81
Novel (ovario) leukodystrophy related to AARS2 mutations 79
Targeting defects in assembly of the mitochondrial respiratory chain complexes by exploiting yeast models 78
Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis 75
Yeast model of mitochondrial involvement of Aβ amyloidotic neurodegeneration 70
MTO1 MUTATIONS CAUSE RESPIRATORY CHAIN DEFICIENCY IN HUMANS AND YEAST 67
From Genetics to Epigenetics: The Steps of a Path 37
Sex-dependent salivary microRNA expression profiles and psychophysiological responses to acute stress in healthy adults 4
Totale 12.444
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.610
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.610
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021147 0 0 0 0 0 0 0 0 0 60 51 36
2021/2022403 22 21 1 27 14 27 35 36 14 33 28 145
2022/20231.457 138 150 101 95 132 155 28 78 502 6 51 21
2023/2024756 57 66 37 28 57 145 39 60 17 74 66 110
2024/20252.544 44 90 122 141 290 385 142 115 358 203 193 461
2025/20265.166 476 527 730 485 742 267 682 172 740 345 0 0
Totale 12.444